Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the differential hemodynamic effects of prostacyclins and sotatercept.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Cardiac Arrest From Sulfur Hexafluoride Contrast Anaphylaxis After Prior Perflutren Hypersensitivity.

JACC. Case reports·2026
Same author

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials.

JACC. Advances·2025
Same author

Mechano-Ino-Chronotropic Unloading in Cardiogenic Shock Due to Acute Myocardial Infarction-Hemodynamic Insights From Simulation Modeling.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

The Advanced Heart Failure Workforce Crisis: A Path Forward.

Journal of cardiac failure·2025

Related Experiment Video

Updated: Jun 3, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

Diuretics as pathogenetic treatment for heart failure.

Maya Guglin1

  • 1University of South Florida, Tampa, FL, USA. mguglin@gmail.com

International Journal of General Medicine
|March 16, 2011
PubMed
Summary

Congestion drives heart failure progression and hospitalizations in both preserved and reduced ejection fraction patients. Fluid removal using diuretics is the only effective treatment, targeting congestion for improved outcomes.

Keywords:
congestiondiastolic functiondiureticsejection fractionheart failuresystolic function

Related Experiment Videos

Last Updated: Jun 3, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

Area of Science:

  • Cardiology
  • Heart Failure Pathophysiology
  • Clinical Outcomes

Background:

  • Congestion, indicated by increased intracardiac filling pressure, is a primary cause of heart failure symptoms and hospital admissions.
  • Hospital admissions for heart failure predict increased morbidity, mortality, and further hospitalizations, highlighting congestion's critical role.
  • Congestion is the shared pathogenetic feature in heart failure with preserved systolic function (HFpEF) and heart failure with reduced systolic function (HFrEF).

Purpose of the Study:

  • To emphasize congestion as the central driver of heart failure progression and outcomes.
  • To highlight the shared pathophysiology and outcomes between HFpEF and HFrEF due to congestion.
  • To underscore the role of fluid removal as the primary pathogenetic therapy for heart failure.

Main Methods:

  • Review of existing literature on heart failure pathophysiology and clinical outcomes.
  • Analysis of the role of intracardiac filling pressure (congestion) in heart failure progression.
  • Evaluation of treatment strategies targeting congestion in heart failure.

Main Results:

  • Congestion dictates symptoms, hospital admissions, morbidity, and mortality in heart failure, irrespective of systolic function.
  • HFpEF and HFrEF exhibit similar outcomes primarily driven by congestion, with minor differences attributed to ejection fraction and ventricular remodeling.
  • Fluid removal (diuretics, ultrafiltration, dialysis) is the sole treatment effective for both HFpEF and HFrEF as it directly addresses congestion.

Conclusions:

  • Congestion is the pivotal pathogenetic mechanism and determinant of outcomes in all forms of heart failure.
  • Effective management of heart failure necessitates targeting congestion through fluid removal therapies.
  • Diuretics represent a pathogenetic therapy for heart failure by alleviating congestion.